The advent of continuous human leukemia-lymphoma cell lines as a rich resource of abundant, accessible and manipulable living cells has contributed significantly to a better understanding of the pathophysiology of hematopoietic tumors. We describe the establishment of the new continuous leukemia cell line MUTZ-8 from a patient with acute myeloid leukemia (AML): MUTZ-8 was derived from the peripheral blood of a 63-year-old woman with AML M4 (25 years after onset of myelodysplastic syndromes, MDS). DNA fingerprinting confirmed authenticity and derivation of the cell line. The immunoprofiling as determined by flow cytometry showed that MUTZ-8 is positive mainly for myeloid but also some monocytic and megakaryocytic markers, whereas it is negative for T cell, B cell and erythroid markers. The cell line is constitutively cytokine-dependent, proliferation requiring externally added cytokines. The cytokine response profiles showed a two-to 10-fold growth stimulation of the cells by various cytokines, whereas other cytokines led to growth inhibition. Cytogenetic analysis confirmed the common clonal derivation of the cell line and the malignant clone predominating at the times of sampling. MUTZ-8 displays a deletion of the 5q31 AML/MDS region effected by a non-reciprocal translocation, t(5;11)(q21;q10). The scientific utility of MUTZ-8 lies (1) in its cluster of pathognomonic cytogenetic alterations including a 5q31 breakpoint and (2) in its absolute cytokine dependency and proliferative response to various cytokines.
Introduction
Until the advent of purified and subsequently recombinant cytokines, human leukemia cell lines were grown in various media supplemented only with ill-defined fetal bovine serum (FBS) rather than specific exogenous hematopoietic growth factors (so-called 'autonomous growth'). 1 The availability of cytokines stimulated further progress in the culturing of leukemia cells. Over the last 10 years a spectrum of factor-dependent cell lines has been established from patients with various types of leukemia that are strictly dependent on exogenous growth factors for proliferation and survival. 2 These cytokines include some of the interleukins (eg IL-2, IL-3, IL-6), the socalled colony-stimulating factors (CSF) such as granulocyte-, granulocyte-macrophage-, and macrophage-CSF (G-CSF, GM-CSF, M-CSF), and stem cell factor (SCF). Many of these cell lines can be grown continuously with either IL-3 or GM-CSF which reflects the ability of these cytokines to stimulate early progenitor and immature cells. Furthermore, while in general most cell lines cannot be grown in long-term culture or even continuously with the majority of factors other than those mentioned above, they are often 'responsive' to a variety of cytokines in terms of short-term enhanced proliferation or sustained survival. Withdrawal of the supporting growth factor leads commonly to apoptosis within a short time period. Clearly, the establishment of factor-dependent cell lines allowed for the continuous growth of leukemia cells that were previously eliminated during selection in standard culture medium as well as illuminating additional, presumably early, phases of hemic tumorigenesis. These factor-dependent cell lines are important models for cytokine signal transduction as well as proliferative responses and differentiation. 3 In addition, factor-dependent cell lines provide a window on a constituent of the malignant cell population which might otherwise remain invisible.
Another area where cell lines have made important contributions is in the field of classical and molecular cytogenetics. The occurrence of chromosome changes in cancer has long been recognized. It became apparent that the changes occur non-randomly and that different types of chromosome change characterize the various different cancers. Recurrent chromosome rearrangements, particularly balanced translocations in hematopoietic neoplasms, effect specific gene rearrangements such as fusion oncogene formation. Various cell lines have been instrumental in the cytogenetic detection of specific alterations and cloning of the genes involved (for reviews, see Refs 4 and 5).
In turn, pathognomonic chromosome changes provide the best available markers for tracing the neoplastic linkage between cell lines and the original tumor populations with which they are supposed to share a common ancestry. The new leukemia cell line, MUTZ-8, which displays mainly myeloid characteristics, has been derived from a patient with acute myeloid leukemia (AML) with a history of myelodysplastic syndromes (MDS). Here, we determined the proliferative or anti-proliferative response of cell line MUTZ-8 to various cytokines which are known to have mitogenic or inhibitory effects on hematopoietic cells. Upon cytogenetic characterization of the cells, we discovered that MUTZ-8 carries a chromosomal rearrangement effecting deletion of the 5q31 AML/MDS consensus region which renders this cell line a unique and important research tool for the further analysis of this chromosomal alteration.
Materials and methods

Case report
The MUTZ-8 cell line was derived from a 63-year-old Caucasian woman with AML M4 (at the Princess Margaret Hospital, Toronto, Canada). The patient had suffered from MDS for 25 years and had received Ara-C (cytarabine) for about 2 years before her MDS progressed to frank leukemia in June 1994. The patient was then treated with chemotherapy including Ara-C, but the patient responded poorly to the treatment, failing to achieve remission. [9] , −7 [9] , der(11) [9] , −11 [5] , der(12) [9] .
Cell culture
The cells were cultured in 24-well plates at a density of 5 × 10 5 /ml in ␣-MEM medium supplemented with 15% heatinactivated FBS, 15% supernatant (conditioned medium) of 5637 cells (5637 CM) and 10 ng/ml of both G-CSF and GM-CSF at 37°C in an atmosphere of 5% CO 2 in air. The medium was exchanged every 3-5 days depending on the cell growth rate. The cells were examined daily under an inverted microscope and the cell number counted weekly in a standard hematocytometer using trypan blue dye exclusion to determine viability. Fresh medium was added regularly to keep the cells at a density of 5 × 10 5 /ml. After 2 weeks, the cell number had increased two-to three-fold and then the cells were transferred to flasks for further continuous culture. The recombinant cytokines were omitted from the culture medium after 4 weeks while 5637 CM was continuously used as the source of growth factors for maintaining proliferation.
Characterization of MUTZ-8 cells
Details of the various methods employed for the identity/quality control and characterization of the cell line have been described elsewhere: DNA fingerprinting, immunophenotyping using flow cytometry and fluorescence microscopy, viral and mycoplasmal evaluation. 2, [5] [6] [7] [8] [9] [10] [11] The antigens examined on MUTZ-8 cells are listed in Table 1 . The following viruses were examined by DNA and reverse transcriptase-polymerase chain reaction: Epstein-Barr virus (EBV), hepatitis B and C viruses (HBV, HCV), human immunodeficiency virus (HIV), and human T cell leukemia viruses (HTLV)-I/II. 9 
Cytogenetics
Cytogenetic harvesting, slide preparation, trypsin G-banding (GTG) and fluorescence in situ hybridization (FISH) were performed as described previously.
12 FISH was performed according to manufacturers' protocols using single-locus and whole-chromosome ('painting') probes obtained from Cambio (Cambridge, UK) and AGS (Heidelberg, Germany) together with the following single locus probes: AML/MDS consensus region (5q31), CCND1 (11q13), MLL (11q23), PML (15q22), RARA (17q21) obtained from Vysis (Bergisch Gladbach, Germany), QBiogene (Illkirch, France), and Roche Molecular Biochemicals (Mannheim, Germany). Preparations were counterstained with 4Ј-6-diamidino-2-phenylindole (DAPI) (Camon, Wiesbaden, Germany). Probe signals were detected directly or indirectly using anti-digoxigenin-FITC (QBiogene) or avidin-Texas-Red (AGS). Octachrome multiprobe FISH (m- The numbers represent the percentages of the positive cells detected by the respective antibody. Except for CD68 ('cy' for cytoplasmic vs the otherwise examined surface membrane expression), MPO and TdT which were detected by immunostaining of cytospin slides, antigen positivity was evaluated by flow cytometry. MPO, myeloperoxidase; sIg, surface immunoglobulin; TCR, T cell receptor; TdT, terminal deoxynucleotidyl transferase.
FISH) probes which enable panoptic analysis of all 24 chromosomes on a single slide using eight triplet probe combinations were purchased from QBiogene. Images were captured using a CCD camera configured to a fluorescence microscope (Zeiss, Gö ttingen, Germany) equipped with appropriate filters. Images were merged and analyzed using monochromatic special software (Quips, Applied Imaging, Newcastle, UK).
Proliferation assays
The proliferative responses of the cell line to various hematopoietic effector molecules were examined by standard 3 H-thymidine incorporation and ␤-scintillation counting. The cells were seeded in triplicate in 100 l medium in flat-bottomed 96-well plates at 0.05-0.2 × 10 6 cells/ml and incubated in the absence or presence of cytokines; for the last 4 h of the 48 h incubation period, 1Ci methyl-3 H-thymidine (Amersham, Braunschweig, Germany) was added to each well. All 3 H-thymidine incorporation assays were performed at least twice on different occasions, each assay performed in triplicate. The following commercially supplied cytokines (listed in alphabetical order) were used: erythropoietin (EPO; final concentration 5 U/ml), G-CSF (10 ng/ml), GM-CSF (10 ng/ml), interferon-␣ (IFN-␣; 50 ng/ml), IFN-␤ (50 ng/ml), IFN-␥ (50 ng/ml), IL-1␣ (10 ng/ml), IL-2 (10 ng/ml), IL-3 (10 ng/ml), IL-4 (10 ng/ml), M-CSF (50 ng/ml), SCF (100 ng/ml), transforming growth factor-␤1 (TGF-␤1; 50 ng/ml), tumor necrosis factor-␣ (TNF-␣; 50 ng/ml), and TNF-␤ (50 ng/ml). Cytokines were obtained from Roche, Mannheim, Germany and R&D Systems, Wiesbaden, Germany. Thrombopoietin (TPO; 100 U/ml), FLT3 ligand (FLT3L; 100 ng/ml) and PIXY-321 (GM-CSF/IL-3 fusion protein; 10 ng/ml) were kindly provided by Zymogenetics (Seattle, WA, USA) and Immunex (Seattle, WA, USA). Conditioned medium (CM at 10% v/v) from the human bladder carcinoma cell line 5637 9 was used as a positive control. Further details on this type of cytokine experiments have been described previously.
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Results and discussion
The human leukemia cell line MUTZ-8 was established from the peripheral blood of an individual with secondary AML M4 which had evolved from MDS at the diagnosis of the overt leukemia in 1994. Cell culture characteristics of MUTZ-8 are presented in Table 2 . The cells are negative for various viruses and for mycoplasma ( Table 2 ). This cell line has been grown in culture for more than 1 year and thus represents a continuous cell line. 5 The main features of these cells have remained stable during this culture period and also after freezing and thawing.
This cell line grows as single cells in suspension without adhering to plastic. The morphology of MUTZ-8 is highly irregular with virtually every cell presenting a different morphology (monoclonality has, however, been confirmed at the cytogenetic level): the cells are rarely regularly shaped; most cells display cytoplasmatic blebs; the cytoplasm is slightly basophilic with variable prominent vacuolization; the cells contain either one polymorph nucleus (with a variety of bizarre bi-/polylobulated, clefted, indented, kidney-shaped or other nuclear forms) or several nuclei (Figure 1) .
The detailed immunophenotypic characterization of the MUTZ-8 cell line is summarized in Table 1 . This immunoprofile corresponds to those of myeloid cells: positivity for the myeloid markers CD13, CD15, CD33, CD65, CD68, MPO, the adhesion markers CD11a/b/c, CD54, and the Fc-receptors CD32, CD64; lack of expression of any T or B cell-associated markers. MUTZ-8 is also reproducibly positive for the monocytic antigen CD14 and the megakaryocytic markers CD41 and CD42b. As expected, the cells display receptors for GM-CSF (CD116), IL-3 (CD123), and SCF (CD117).
MUTZ-8 has a predominantly hypotetraploid composition though iterative hypodiploid cells, analogous to those described at diagnosis, were also present. The consensus karyotype was as follows: 86-88<4n>XXXX, der(5)t(5;11) (q21;q10)x2, −7, −7, −11, der(11;12)(p10;q10), −16, der(17)t(10;17)(q11;q24)?dup(17)(p13pter)x2. A representative karyogram is presented in Figure 2a . Recurrent leukemogenic changes displayed by MUTZ-8 include t(5;11)(q21;q10) occurring nonreciprocally, thereby effecting deletion of the 5q21-qter region, and loss of chromosome 7. FISH using a locus-specific probe confirmed deletion of the consensus 5q31 region (Figure 2b ) while m-FISH confirmed both der(5) and −7 changes in the hypodiploid clone (Figure 2c ). Additional FISH analysis using a probe specific for the chromosome 11 centromere region showed that the breakpoint in chr. 11q lies in the ␣-satellite DNA region in der(5) (Figure 2b inset) and der(11;12) (data not shown), rearrangements suggesting their formation via a complex exchange involving all three chromosomes 5, 11 and 12.
Despite the rather attenuated homogeneously staining appearance of the der(17)t(10;17) as revealed by standard Gbanding (Figure 2a) , neither conventional chromosome painting nor m-FISH analyses indicated the presence of any extraneous material (Figure 2c ). Hence the extended p-arm region of this marker was interpreted as a duplication, although a more complex rearrangement cannot be excluded. It is known that homogeneously staining regions (HSR) regularly arise via gene amplification. However, hybridization with a CMYC probe failed to detect amplification of this oncogene as occurs in the AML-derived cell line HL-60 which has a karyotypic structure reminiscent of MUTZ-8, including 5q−.
In addition to partial loss of 5q and −7, MUTZ-8 displays copy number changes affecting the following regions: losses of 12p10→pter and 17q24→qter; and gains of 10q11→qter and 11q10→qter (Figure 2c ). Hybridization with probes for additional oncogenes commonly rearranged in AML revealed nothing untoward: namely MLL at 11q23, PML at 15q22, RARA at 17q21 and CCND1 at 11q13 (given its proximity to the 11q breakpoint) (Figure 2b inset) .
The detailed karyotypic structure of MUTZ-8 closely matches that performed at diagnosis of florid disease confirming derivation from the dominant malignant clone, and that the principal rearrangements, t(5;11) and −7, arose in vivo. Concordant DNA fingerprint profiles from paired primary and cell line material confirmed provenance, while the uniqueness of its DNA fingerprint profile (cf. the DSMZ inhouse databank) excluded cell line cross-contamination which is known to be rife, affecting 18% of new cell lines. 13 Deletions targeting 5q31 as the minimally deleted region (5q−) is a recurrent change present in about 10% new cases of AML/MDS rising to 40% in those receiving treatment. 14, 15 The accompanying deletion of chromosome 7 is also associated with AML/MDS, occurring alone or in combination with 5q−. Breakage effecting whole-arm translocations in AML/MDS, ie targeting centromeric DNA, such as that involved in both t(5;11) and t(11;12) rearrangements, has been taken as an indication of therapy-induced damage. 16 Coinci- 
Genetic characterization: Cytogenetic karyotype 86-88<4n>XXXX, der(5)t(5;11)(q21;q10)x2, −7, −7, −11, der(11;12)(p10;q10), −16, der (17) Comments Cell type myelomonocytic cell line Scientific significance cytokine-dependent/-responsive; unique karyotype with 5q31 breakpoint
Figure 1
Morphology of MUTZ-8 cells. Cytospin slide preparations of MUTZ-8 cells were stained with May-Grü nwald-Giemsa. Photomicrograph was taken with a Zeiss Axioplan photomicroscope using oil immersion and a ×63 planapochromat objective.
Leukemia dent with the breakpoint at 17p13 in der(17)t(10;17), we observed loss of heterozygosity (LOH) in the region of p53 at 17p13 affecting the polymorphic allele D17S5 (data not shown). Christiansen et al 17 have recently shown that LOH at p53 is associated with 5q− after chemotherapy. The patient from whom the MUTZ-8 cell line was established had been receiving chemotherapy with Ara-C (cytarabine) for 2 years, consistent with a cytogenetic picture suggestive of multiple therapy related changes as compiled by Johansson et al. 18 Furthermore, the involvement of the 11q10 centromeric breakpoint housing ␣-satellite DNA in which genes are highly depleted or absent suggests a pathological function for both translocations, der(5) and der (11;12) , in terms of genic deletion (or inactivation) rather than fusion. Indeed, loss of 12p has been associated with transformation from MDS to AML, 19 while the t(10;17) change targets a breakpoint on 17q close to that reported by the same authors to be recurrent in MDS.
MUTZ-8 is only the second MDS cell line after MUTZ-1 20 in which 5q− has been reported. However, MUTZ-8 appears to model the cytogenetic picture of 5q− in AML/MDS with much greater clarity as the karyotype of MUTZ-1 (which was established from a Fanconi anaemia patient) is rearranged to (5)t(5;11) and der(17)t(10;17), together with loss of two copies of chromosome 7, indicating formation in a progenitor diploid clone. The der(11;12) (arrow), although present in a single copy only, occurs in the weaker hypodiploid clones also. Image (b) shows the result of FISH analysis revealing the composition of the der(5)t(5;11). The main figure shows a hypodiploid cell cohybridized with painting (Spectrum Red label) and 5q31 single locus (digoxigenin label detected with green FITClabelled antibody) probes (Qbiogene). Note loss of the 5q31 consensus MDS/AML region via the non-reciprocal t(5;11)(q21;q10).Inset in image (b) shows cohybridization with directly labelled single locus probes for chr. 11 ␣-satellite DNA (green fluor) and CCND1 at 11q13 (red fluor) (Vysis). Note the presence of dual signals in both chromosome 11 and der(5)t(5;11) -placing the chr. 11 breakpoint firmly in the centromeric region (and outwith the CCND1 region). Chr. 11 ␣-satellite DNA is also present in the der(11;12) (data not shown), implying collaborative formation of both t(5;11) and t(11;12). In both figures chromosomes were counterstained with DAPI. Image (c) shows the results of m-FISH performed on an hypodiploid cell using the Octachrome system (Qbiogene) after painting with directly labelled probes for chr. 5 (red), chr. 7 (green) and chr. 10 (blue) without counterstain. Note the absence of one chr. 7 homolog and respective gain and loss of chr. 10 and chr. 5 material via the non-reciprocal t(10;17) and t(5;11). Eight such hybridizations were performed covering all 23 possible homologs. Single-passband filtered monochromatic FISH images were captured, merged, and analyzed using Quips software (Applied Imaging). a degree unprecedented among other AML/MDS cell lines and has yet to be fully resolved cytogenetically. In contrast, the changes present in MUTZ-8 are moderate -most having been described previously in AML/MDS.
In addition to modelling AML/MDS in vitro, MUTZ-8 provides a renewable resource of obvious interest to those seeking the presumptive mutational targets of 5q− and 7q deletions, identification of which has proved so elusive hitherto. As a bonus, the presence of breakpoints involving repetitive satellite DNA derived from chromosome 11 should assist precise identification of the 5q21 breakpoint involved and be of likely interest to those investigating treatment-induced genomic changes in MDS by sequencing breakpoint junctions. MUTZ-8 provides hitherto the best cytogenetic model and resource for MDS, carrying both of the changes (5q− and −7) most closely associated with this disease entity.
The proliferative response to cytokines was examined by the 3 H-thymidine assay. The results of representative experiments are presented in Figure 3 . Using a cut-off value of twofold stimulation compared with the untreated control cells in three to five independent experiments, MUTZ-8 cells were significantly stimulated by the 5637 CM (4.2-to 9.4-fold compared with the untreated control) and the cytokines G-CSF (2.4-to 5.4-fold), GM-CSF (3.6-to 7.2-fold), IL-3 (4.4-to 9.3-fold), PIXY-321 (4.0-to 10.6-fold), and SCF (3.3-to 7.1-fold). The response of MUTZ-8 to M-CSF was at several occasions borderline: 1.9-to 2.3-fold stimulation. With a cut-off value of 50% of untreated control, the following molecules had significant inhibitory effects on MUTZ-8 proliferation: TGF-␤1 (40-75% of control), TNF-␣ (40-65%), TNF-␤ (50-100%). Thus, MUTZ-8 cells show a cytokine response profile similar to those of other AML-derived cell lines. 2 Taken together, the scientific significance of the new AMLderived MUTZ-8 leukemia cell line lies (1) in its unique karyotype including a 5q31 breakpoint and (2) in its cytokine dependency and responsiveness. The salient features of cell line MUTZ-8 are summarized in Table 2 . The cell line is available for research purposes. 
